{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,24]],"date-time":"2026-01-24T01:03:31Z","timestamp":1769216611589,"version":"3.49.0"},"reference-count":15,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2005,5,1]],"date-time":"2005-05-01T00:00:00Z","timestamp":1114905600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clinics in Dermatology"],"published-print":{"date-parts":[[2005,5]]},"DOI":"10.1016\/j.clindermatol.2004.06.015","type":"journal-article","created":{"date-parts":[[2005,5,15]],"date-time":"2005-05-15T11:13:40Z","timestamp":1116155620000},"page":"223-226","source":"Crossref","is-referenced-by-count":18,"title":["Life-threatening bullous dermatoses: Pemphigus vulgaris"],"prefix":"10.1016","volume":"23","author":[{"given":"Eleonora","family":"Ruocco","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adone","family":"Baroni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ronni","family":"Wolf","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vincenzo","family":"Ruocco","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.clindermatol.2004.06.015_bib1","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1046\/j.1523-1747.1999.00626.x","article-title":"Common human leukocyte antigen alleles in pemphigus vulgaris and pemphigus foliaceus Italians patients","volume":"113","author":"Lombardi","year":"1999","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.clindermatol.2004.06.015_bib2","first-page":"299","article-title":"Pemphigus and environmental factors","volume":"138","author":"Ruocco","year":"2003","journal-title":"G. Ital. Dermatol. Venereol."},{"key":"10.1016\/j.clindermatol.2004.06.015_bib3","series-title":"European handbook of dermatological treatments","first-page":"390","article-title":"Pemphigus vulgaris","author":"Ruocco","year":"2003"},{"key":"10.1016\/j.clindermatol.2004.06.015_bib4","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1067\/mjd.2003.581","article-title":"Evaluating the role of immunoablative high-dose cyclophosphamide therapy in pemphigus vulgaris","volume":"49","author":"Nousari","year":"2003","journal-title":"J. Am. Acad. Dermatol."},{"key":"10.1016\/j.clindermatol.2004.06.015_bib5","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1001\/archderm.138.9.1158","article-title":"Corticosteroid-sparing effect of intravenous immunoglobulin therapy in patients with pemphigus vulgaris","volume":"138","author":"Sami","year":"2002","journal-title":"Arch. Dermatol."},{"key":"10.1016\/j.clindermatol.2004.06.015_bib6","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1001\/archderm.139.8.1051","article-title":"For the consensus development group. Consensus statement on the use of intravenous immunoglobulin therapy in the treatment of autoimmune mucocutaneous blistering diseases","volume":"139","author":"Ahmed","year":"2003","journal-title":"Arch. Dermatol."},{"key":"10.1016\/j.clindermatol.2004.06.015_bib7","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1001\/archderm.139.8.991","article-title":"Stroke and deep venous thrombosis complicating intravenous immunoglobulin infusions","volume":"139","author":"Kats","year":"2003","journal-title":"Arch. Dermatol."},{"key":"10.1016\/j.clindermatol.2004.06.015_bib8","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1111\/j.1365-2133.1978.tb01630.x","article-title":"Pathogenicity of the intercellular antibodies of pemphigus their periodic removal from the circulation by plasmapheresis","volume":"98","author":"Ruocco","year":"1978","journal-title":"Br. J. Dermatol."},{"key":"10.1016\/j.clindermatol.2004.06.015_bib9","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1159\/000249707","article-title":"Plasmapheresis as an alternative or adjunctive therapy in problem cases of pemphigus","volume":"168","author":"Ruocco","year":"1984","journal-title":"Dermatologica"},{"key":"10.1016\/j.clindermatol.2004.06.015_bib10","doi-asserted-by":"crossref","first-page":"1702","DOI":"10.1001\/archderm.124.11.1702","article-title":"Plasmapheresis therapy of pemphigus","volume":"124","author":"Bystryn","year":"1988","journal-title":"Arch. Dermatol."},{"key":"10.1016\/j.clindermatol.2004.06.015_bib11","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1067\/mjd.2000.109297","article-title":"The use of plasmapheresis and immunosuppression in the treatment of pemphigus vulgaris","volume":"43","author":"Turner","year":"2000","journal-title":"J. Am. Acad. Dermatol."},{"key":"10.1016\/j.clindermatol.2004.06.015_bib12","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1172\/JCI117349","article-title":"Absorption of pathogenic autoantibodies by the extracellular domain of pemphigus vulgaris antigen (Dsg3) produced by baculovirus","volume":"94","author":"Amagai","year":"1994","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.clindermatol.2004.06.015_bib13","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1046\/j.1365-2133.2003.05513.x","article-title":"Successful removal of pathogenic autoantibodies in pemphigus by immunoadsorption with a tryptophan-linked polyvinylalcohol adsorber","volume":"149","author":"L\u00fcftl","year":"2003","journal-title":"Br. J. Dermatol."},{"key":"10.1016\/j.clindermatol.2004.06.015_bib14","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1046\/j.1365-2133.2003.05209_10.x","article-title":"Treatment of pemphigus vulgaris with anti-CD 20 monoclonal antibody (rituximab)","volume":"148","author":"Herrmann","year":"2003","journal-title":"Br. J. Dermatol."},{"key":"10.1016\/j.clindermatol.2004.06.015_bib15","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1001\/archderm.140.1.91","article-title":"Treatment of refractory pemphigus vulgaris with rituximab (anti-CD20 monoclonal antibody)","volume":"140","author":"Dupuy","year":"2004","journal-title":"Arch. Dermatol."}],"container-title":["Clinics in Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0738081X04001154?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0738081X04001154?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,1,26]],"date-time":"2019-01-26T13:21:11Z","timestamp":1548508871000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0738081X04001154"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,5]]},"references-count":15,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2005,5]]}},"alternative-id":["S0738081X04001154"],"URL":"https:\/\/doi.org\/10.1016\/j.clindermatol.2004.06.015","relation":{},"ISSN":["0738-081X"],"issn-type":[{"value":"0738-081X","type":"print"}],"subject":[],"published":{"date-parts":[[2005,5]]}}}